Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05875103
Other study ID # PI2022_843_0150
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 16, 2023
Est. completion date June 2024

Study information

Verified date June 2023
Source Centre Hospitalier Universitaire, Amiens
Contact Martine ROUSSEL, PhD
Phone 0322668240
Email roussel.martine@chu-amiens.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Verbal fluency test require to produce as much words as possible in one or two minutes. This test is highly sensitive to main brain diseases and are therefore widely used in clinical routine for diagnostic purpose. The verbal fluency task requires several cognitive processes including executive and linguistic processes for which it is difficult to extract the origin of the deficit. For this reason, fluency tests are variably interpreted in terms of executive or language. The implementation of an experimental protocol exploring each of these processes separately and studying the links between the verbal fluency task and each of these processes should allow a better understanding of the origin of the verbal fluency deficit after brain injury and improve the identification of key brain structures. Indeed, the lesion determinants of this task remain to be clarified despite remarkable advances due to the evolution of imaging techniques (voxel-based lesion-symptom mapping (VLSM); voxel-based morphometry (VBM)). Furthermore, while the direct assessment of linguistic process, semantic memory, and processing speed is well defined, the examination of the executive component (i.e., strategic search process) remains unsettled and will be undertaken in this study. This work will take advantage of data from previous multicenter work, validated methodologies for both analysis and interpretation of cognitive performance as well as anatomic-clinical correlations at the voxel level and will be performed in cognitive neurodegenerative and cerebrovascular disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 88
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - For Cognitive cortical neurodegenerative diseases PATIENTS - informed consentPatients between 40 and 85 years old, - French native language, - Social Security affiliation, - Can read, write and count (up to 36) and knows the alphabet - Assessed in Amiens University Memory Clinic for: - Mild severity impairment (MMSE> 19) or major severity impairment related to: - AD according to Albert criteria and McKhann criteria - DCL according to McKeith criteria - FTLD according to Rascovsky criteria - CBD according to Armstrong's criteria - PSP according to Höglinger criteria - For Stroke PATIENTS - informed consent - Patients between 40 and 85 years old, - French native language, - Social Security affiliation, - Can read, write and count (up to 36) and knows the alphabet - Having suffered a stroke, hospitalized in neurology, visualized by imaging Exclusion Criteria: - Mental retardation or guardianship - Other current or past brain condition affecting cognition, including: - Severe head trauma - Epilepsy prior to stroke still requiring previous treatment - Parkinson disease, multiple sclerosis - Brain tumor or brain radiation therapy - Current or past schizophrenia or psychosis - Active or past psychiatric impairments requiring a stay> 2 days in a specialized environment - Contra indication to MRI - Comorbidity with life expectancy <1 year - Comorbidity affecting cognition in particular: - Alcohol (> 3 glasses / day) or history of alcohol withdrawal syndrome - Opiate or cocaine addiction or opiate withdrawal syndrome - Renal failure (dialysis or creatinine clearance <30) - Hepatic failure (spontaneous INR> 1.5 or PT <60%) - Respiratory failure requiring oxygen therapy - Heart failure (orthopnea> 2 pillows) - Persistent vigilance disorder (NIHSS1a score =1) - Cancer with paraneoplastic syndrome - Treatment with gold salts, D Penicillamine or other treatment with cognitive effect - Patient under guardianship or curators or private under public law - Pregnant and / or lactating woman

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
linguistic processes
Linguistic processes are assessed by performance score on the following tests: naming tests : BNT 34 (Colombo & Assal, 1992) and semantic naming adapted from the BECS-GRECO (Merck et al., 2011) vocabulary test (Mill Hill - Deltour, 1993), repetition tests (Gremots - Bézy et al., 2016), articulatory speed (Majerus, 2014 ; Roussel et al., 2012) semantic matching task adapted from the PPT (Howard & Patterson, 1992) and from the BECS-GRECO (Merck et al., 2011), semantic categorization and attributes adapted from the BECS-GRECO (Merck et al., 2011), phonologic and semantic research tasks adapted from the color TMT (D'helia et al., 1996)

Locations

Country Name City State
France CHU Amiens Amiens

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Corelation between Linguistic test performance score and verbal fluency score Linguistic processes are assessed by performance score on the following tests:
BNT 34 and semantic naming adapted from the BECS-GRECO
vocabulary test
repetition tests
articulatory speed
semantic matching task adapted from the PPT and from the BECS-GRECO
semantic categorization and attributes adapted from the BECS-GRECO
phonologic and semantic research tasks adapted from the color TMT
1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis